<DOC>
	<DOC>NCT01255501</DOC>
	<brief_summary>The purpose of this study is to determine the safety, pharmacodynamic and pharmacokinetic profiles of a novel therapeutic drug when administered to healthy volunteers.</brief_summary>
	<brief_title>First in Human Study of NI-0701 in Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Non smokers Able to adhere to study visits and protocol requirements Any clinical safety laboratory measurements value &gt; Grade 1 on WHO Toxicity Scale Established or recurrent history of allergic reactions</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2010</verification_date>
</DOC>